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Abstract
Background: The neural crest is a unique population of cells that arise in the vertebrate ectoderm at the neural
plate border after which they migrate extensively throughout the embryo, giving rise to a wide range of
derivatives. A number of proteins involved in neural crest development have dynamic expression patterns, and it is
becoming clear that ubiquitin-mediated protein degradation is partly responsible for this.
Results: Here we demonstrate a novel role for the F-box protein Cdc4/Fbxw7 in neural crest development. Two
isoforms of Xenopus laevis Cdc4 were identified, and designated xCdc4a and xCdc4b. These are highly conserved
with vertebrate Cdc4 orthologs, and the Xenopus proteins are functionally equivalent in terms of their ability to
degrade Cyclin E, an established vertebrate Cdc4 target. Blocking xCdc4 function specifically inhibited neural crest
development at an early stage, prior to expression of c-Myc, Snail2 and Snail.
Conclusions: We demonstrate that Cdc4, an ubiquitin E3 ligase subunit previously identified as targeting primarily
cell cycle regulators for proteolysis, has additional roles in control of formation of the neural crest. Hence, we
identify Cdc4 as a protein with separable but complementary functions in control of cell proliferation and
differentiation.
Background
During the development of multi-cellular organisms,
cells receive signals and must elicit the appropriate
response. This involves changes in the level and activity
of proteins, and targeted proteolysis represents a rapid
and irreversible mechanism to block protein function.
During regulated proteolysis, proteins are targeted for
degradation by covalent attachment of the 76 amino
acid protein ubiquitin, and the polyubiquitin chains
assembled on the target protein serve as signals for
degradation by the 26S proteasome. Transfer of ubiqui-
tin onto target proteins is catalyzed by a hierarchical
multi-enzyme cascade. An E1 (ubiquitin activating)
enzyme forms a thioester linkage with the carboxyl ter-
minus of ubiquitin, in an ATP-dependent process. Ubi-
quitin is then transferred to an E2 (ubiquitin
conjugating) enzyme. E3 (ubiquitin ligase) enzymes
recruit distinct substrates, allowing ubiquitin transfer,
and confer specificity on the ubiquitin proteasome
system.
RING (Really Interesting New Gene) E3s are the lar-
gest class of E3 ligases, and the human genome encodes
approximately 400 proteins with a RING domain [1].
Conserved cysteines and histidines coordinate two zinc
ions in the RING domain, which is important for the
recruitment and activation of E2 enzymes. Skp1-Cul-
lin1-F-box (SCF) E3 ligases are a large class of modular
RING E3 ligases that have the RING component Roc1
(also known as Rbx1 and Hrt1). Cullin1 forms a scaffold
to recruit the E2 (via Roc1) and the F-box protein (via
binding of the F-box to Skp1) [2,3]. The F-box compo-
nent of these E3 ligases is variable, and different F-box
proteins recruit different substrates via carboxy-terminal
domains, allowing SCF ligases to target a huge number
of substrates [4].
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any medium, provided the original work is properly cited.Cdc4 (also known as Fbw7), one of the most exten-
sively studied F-box proteins, was originally identified in
Saccharomyces cerevisiae, where it was shown to
degrade the cyclin-dependent kinase inhibitor Sic1 [3-8].
In mammals, there are three isoforms of Cdc4: alpha
(a), beta (b)a n dg a m m a( g). These are produced by
alternative splicing of three unique 5’ exons to ten com-
mon 3’ exons, such that the resulting proteins differ
only at their amino termini [9,10]. In mammals, known
Cdc4 substrates include c-Myc, c-Jun, Cyclin E, Notch
intracellular domain, c-Myb,s t e r o lr e g u l a t o r ye l e m e n t
binding proteins (SREBPs) and steroid receptor coactiva-
tor-3 (SRC3) [9,11-15]. Given these substrates, it is per-
haps unsurprising that Cdc4 has been shown to be a
haplo-insufficient tumor suppressor gene [16]. This list
of substrates also suggestst h a tC d c 4c o u l dr e g u l a t e
developmental events, and attempts to generate knock-
out mice led to an embryonic lethal phenotype [17]. We
became interested in a role for Cdc4 during neural crest
development in particular because several of its sub-
strates have been implicated in the development of this
tissue, for example, c-Myc and Notch intracellular
domain [18,19].
The neural crest is a unique population of cells, aris-
ing at the neural plate border in response to bone mor-
phogenetic protein, Wnt and fibroblast growth factor
signaling (for reviews, see [20,21]). Neural crest cells are
initially multipotent, but subsequently undergo an
epithelial to mesenchymal transition and migrate
throughout the embryo, where they give rise to a wide
range of derivatives (for reviews, see [22,23]). These
include the neurons and glia of the peripheral nervous
system, the autonomic nervous system, cartilage, bone,
connective tissue, cardiac cells and melanocytes. The
induction of the neural crest is often defined according
to the expression of neural crest specifier genes, includ-
ing the transcriptional repressors Snail2 and Snail
[24,25]. A number of proteins involved in neural crest
development display dynamic expression patterns, and it
is becoming apparent that several are targets of the ubi-
quitin proteasome system. For example, Snail2 is
degraded by the F-box protein Partner of paired (Ppa)
[26].
Here we describe identification of the Xenopus laevis
homologues of Cdc4, which are highly conserved at the
sequence level, and are also functionally equivalent in
terms of their ability to degrade Cyclin E. Two isoforms
of Xenopus Cdc4 (xCdc4a and xCdc4b) are found to be
dynamically expressed throughout early Xenopus devel-
opment, with particular enrichment in neural crest and
neural crest-derived tissues. Inhibition of xCdc4 activity,
using dominant negative F-box mutants, blocks neural
crest development, without affecting cell division or cell
survival, nor affecting development of the other tissues
in which they are expressed. Thus, Cdc4 directly and
specifically regulates neural crest formation, independent
of a previously described ability to regulate the cell
cycle.
Results
X. laevis encodes two isoforms of Cdc4: xCdc4a and
xCdc4b
The pseudotetraploid genome of X. laevis presents
unique challenges to identifying genes reported in other
model systems. In contrast, Xenopus tropicalis is pos-
sessed of a diploid genome, making it well suited for
genetic manipulation and bioinformatic analysis. The
existence of X. tropicalis and X. laevis in the same
genus - therefore sharing a high level of evolutionary
conservation between their respective genes - suggested
to us a method of harnessing the sequenced genome of
X. tropicalis to identify potential orthologs of human
Cdc4 (hCdc4) present in X. laevis.B L A S To fh C d c 4 a
(GenBank accession number AY049984) against the X.
tropicalis genome revealed a sequence on scaffold
60:1694203-1694241 with strong nucleotide complemen-
tarity to the first exon of hCdc4a. Further downstream
(scaffold 60:1696322-1,729,489) were exons 2 to 11,
whose sequence corresponded to the conserved regions
found within hCdc4.
PCR primers targeting the identified xCdc4 sequence
were used on oligo d(T) primed mRNA derived from
stage 20 X. laevis embryos. We performed 5’ and 3’
rapid amplification of cDNA ends (RACE) to isolate a
full length product. Although slightly truncated, the pro-
tein was most similar to the b isoform of hCdc4 and has
been designated xCdc4b (Additional file 1). Analysis of
the aligned regions demonstrates that xCdc4b was 98%
identical at the amino acid level and 83% identical at
the nucleotide level to hCdc4b.I nc o m p a r i s o nt oo t h e r
X. laevis F-box proteins, xCdc4b was 27% identical and
43% similar to b -TRCP (b -Transducin repeat contain-
ing protein; GenBank accession number M98268) [27],
and 17% identical and 20% similar to Skp2 (GenBank
accession number DQ228920) [28].
A second isoform of xCdc4 was similarly cloned from
stage 7 X. laevis embryos (GenBank accession number
DQ666345). Exon 1 was found on scaffold 60:1646293-
1646793. Analysis demonstrated nearly perfect conserva-
tion at the amino acid level to the common set of exons,
2 to 11, that occur in hCdc4a and hCdc4b (data not
shown). Additionally, the second identified xCdc4 con-
tained an amino terminal exon most similar to the one
present in human Cdc4a and is referred to hereafter as
xCdc4a. Furthermore, exon 1 of xCdc4b is spliced to
the same downstream exons, 2 to 11, used by xCdc4a.
Alignment of their amino acid sequences showed strong
conservation; differences in amino acid identity being
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Furthermore, both the isoform specific nuclear localiza-
tion signal (amino acids 11 to 14) and common nuclear
localization signal (amino acids 169 to 172) found in
hCdc4a are present in xCdc4a, which is suggestive of a
similar pattern of localization and regulation [29].
From the region of the gene corresponding to the sec-
ond exon, xCdc4a and xCdc4b are 99.8% identical
(1,623 out of 1,626 nucleotides identical). A single
amino acid substitution was made (changing Gly649 to
Asp) to the xCdc4a coding sequence used here, as this
was conserved in all sequence orthologs. A X. laevis
ortholog of hCdc4g was not detected in either stage 7 or
stage 20 embryos.
xCdc4a and xCdc4b proteins are expressed throughout
development, including prominent expression in the early
neural crest
Next, the temporal expression of xCdc4a and xCdc4b
was examined during X. laevis development. Staged
embryo lysates were separated by SDS PAGE and wes-
tern blotted using antibodies to detect the two different
isoforms, xCdc4a and xCdc4b. Anti-Cdc4 3B7 (referred
to as anti-Cdc4a) detected both endogenous and in
vitro translated xCdc4a (Figure 1A). Although unable to
detect endogenous levels of xCdc4b,t h i sa n t i b o d y
weakly detected overexpressed xCdc4b (data not
shown). Anti-Cdc4 3A9 (referred to as anti-Cdc4b)
detected endogenous and in vitro translated xCdc4b
(Figure 1B) Anti-Cdc4b also detected xCdc4a,a l t h o u g h
less effectively than anti-Cdc4a (data not shown). Thus,
western blotting demonstrates that both xCdc4 isoforms
were expressed at all stages tested, from fertilized egg
until stage 28.
The spatial distribution of xCdc4 transcripts during X.
laevis embryogenesis was also examined by in situ
hybridization (ISH) using a probe that would recognize
both isoforms of xCdc4. Prior to stage 15, xCdc4 tran-
scripts were expressed in a diffuse pattern in the ecto-
derm (data not shown). At stage 15, while more diffuse
background staining remained, transcripts accumulated
at the highest level in the neural crest, forming at the
preplacodal ectoderm (Figure 1C, ppe) at the border of
the epidermis and neural plate and in particular in the
presumptive optic placode (Figure 1C, pop). At late
neurula stages, xCdc4 transcripts are detected in the
trunk (Figure 1D, E, TNc) and branchial neural crest
(Figure 1D, b) as well as in the optic placode (Figure 1E,
Opt P), and this staining pattern persists until stage 20
(Figure 1D, E). While continuing to be expressed in the
neural crest derivatives (cranial neural crest (Cc) and
branchial arches (Ba) at later stages (Figure 1F-G))
xCdc4 was additionally expressed in the myotome (Fig-
ure 1G, H, My). From stage 26, staining of the posterior
somites (s) and the neural crest-derived branchial arches
(Ba) persists, while staining in the fin mesenchyme (Fin),
another neural crest-derived tissue, becomes prominent
(Figure 1I-K). Expression in anterior placodes also
becomes pronounced at stage 32 (Figure 1K, arrow-
heads). Staining was not observed with the sense control
probe (Figure 1L-N). In summary, xCdc4 transcripts
were detected in the neural crest and placodes, neural
crest-derived tissues, and additionally in the brain and
somites. We compared the expression of xCdc4 with
other markers of neural crest and placodes: Snail2 (also
known as Slug), Snail, Sox10, Six1, Opl and Pax3 at
stages 15/16, 18/19, 21/22, 26/27 and 32/33 [25,30-34]
(Figures 2 and 3). At neurula and early tailbud stages,
although xCdc4 shows a distinct expression pattern
from each of these markers, its expression overlapped
both in placodal regions and at the border of the epider-
mis and neural plate, where early neural crest arises
(Figure 2). Similarly, at later stages xCdc4 expression in
the branchial arches (Ba), pharyngeal pouches (Pp), cra-
nial ganglia (Cg) and olfactory placode (Olf P) over-
lapped most significantly with the neural crest marker
Snail and placodal marker Six1 (Figure 3).
Surface expression of xCdc4 was clear by whole
mount ISH and was most prominent in neural crest and
placodal regions. However, we saw less distinct staining
more widely across the embryo and in other tissues,
such as the myotome and potentially the neural tube
(for example, Figure 1G), especially when the staining
period was lengthened. Whole mount ISH is most suited
to detect expression in tissues near to the embryo sur-
face. To look more closely at xCdc4 expression in deep
tissues, we performed ISH on sections. When allowing
the ISHs to develop for 2 days, xCdc4 expression was
seen throughout dorsal ectodermal and mesodermal tis-
sue of the embryo, including in the neural plate/tube,
epidermis, myotome and the notocord, with somewhat
weaker staining in the epidermis (Figure 4A, B, G-I),
while no staining was seen in the sense control (Figure
4E, F, J-L), demonstrating specificity. In agreement with
our whole mount staining (Figure 1D), as the neural
tube was closing, expression of xCdc4 appears strongest
in areas lateral to the neural plate (Figure 4B) that also
express Snail2 (Figure 4D), and so are developing neural
crest. While other tissues also expressed xCdc4, staining
of the neural crest was clear in all embryo sections
examined (Figure 4A, B, G-I, arrows).
xCdc4 degrades Cyclin E and xCdc4ΔFbox mutants act as
dominant negatives
Mammalian Cdc4, and in particular Cdc4a, is known to
target Cyclin E for ubiquitin-mediated proteolysis
[35-38]. We wanted to determine whether xCdc4 could
target Cyclin E for degradation in X. laevis embryos,
both by overexpressing the xCdc4 protein and by
knocking out its function. To block xCdc4 function, we
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Page 3 of 20Figure 1 xCdc4a and xCdc4b protein are expressed throughout development, and transcripts accumulate in the neural crest and
neural crest derived tissues. Expression of (A) xCdc4a and (B) xCdc4b in staged embryo lysates was determined by immunoblotting (IB)
using anti-Cdc4 antibodies. In vitro translated (IVT) protein was used as a control. Equal loading was verified by IB for tubulin, with the equivalent
of one embryo per lane loaded. (C-K) Developmental expression of xCdc4 was determined by whole mount ISH. At stage 15 (C), xCdc4
expression is detected broadly at the preplacodal ectoderm (ppe), in particular in the presumptive optic placode (pop) as well as in the
prospective trunk neural crest (TNc). At late neurula stages (D,E), while xCdc4 transcripts continue accumulating in the trunk neural crest and
optic placode (Opt P), xCdc4 is also detected in the cranial neural crest, particularly within the branchial aggregates (b). At stage 21 (F), xCdc4 is
broadly detected in migrating cranial neural crest (Cc) and placodal regions. At stage 23 (G,H), xCdc4 is expressed in cranial neural crest that
populates the branchial arches (Ba) and additionally in the myotome (My). At stage 26 (I), xCdc4 continues to be expressed in the myotome and
branchial arches, as well as in several anterior placodes (arrowheads). xCdc4 is additionally expressed in the posterior fin mesenchyme (Fin). From
stage 28 to 32 (J,K), xCdc4 expression is downregulated in the branchial arches, while persisting in the anterior placodal region (arrowheads),
dorsal somites (s) and dorsal and ventral fin mesenchyme (Fin). Whole mount ISH at the indicated stages using xCdc4b sense probe confirms
the specificity of the probe (L-N). Views in (C-N) are indicated bottom right after the stage (St): a, anterior view; d, dorsal view; l, lateral view.
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microinjection of antisense morpholino oligonucleotides.
Although xCdc4-directed morpholinos specifically inhib-
ited translation of synthetic mRNA encoding xCdc4a or
xCdc4b, demonstrating their functionality, microinjec-
tion into embryos had only a small effect on xCdc4a
protein levels and no detectable effect on xCdc4b levels,
as detected by western blot (data not shown).
Figure 2 xCdc4 expression overlaps with expression of markers
of neural crest and placodes. (A-R) Comparison of xCdc4
developmental expression (A,G,M) with the expression of neural
crest and placodal gene markers in stage 15/16 (B-F), 18/19 (H-L)
and 21/22 (N-R) embryos, as labeled. Asterisk indicates premigratory
cranial crest; b, branchial crest; Cc, cranial neural crest; di,
diencephalons; dlp, dorsolateral placodal area; Hg, hatching gland;
h, hyoid crest; m, mandibular crest; me, mesencephalon; Nc, neural
crest; Olf P, olfactory placode; Opt P, optic placode; plp,
presumptive lens placode; pOlf P, presumptive olfactory placode;
ppe, preplacodal ectoderm; pop, presumptive optic placode; s,
somites; tel, telencephalon; TNc, trunk neural crest; yellow
arrowhead, neural plate border region of the prospective
rhombencephalon. Anterior view, dorsal up, stages as indicated.
Figure 3 xCdc4 expression overlaps with expression of neural
crest and placodal markers. (A-L). Comparison of xCdc4
developmental expression (A,G) with the expression of neural crest
and placodal gene markers in the mid-tailbud stages 26/27 (A-F)
and 32/33 (H-L). Arrowheads indicate the trigeminal placode; white
asterisks indicate branchial arches; red asterisks indicate pharyngeal
pouches. Ba1-2, branchial arches 1 and 2; Cg, cranial ganglia; Di/Me,
diencephalon and midbrain boundary; E, eye; Ev, ear vesicle; F,
forebrain; Ha, hyoid arch; Hg, hatching gland; M, mandibular arch;
M*, mandibular crest surrounding the eye; Pr, profundal placode;
Tel, telencephalon. Lateral view, anterior left, stages as indicated.
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depend on new translation of mRNAs. Our developmen-
tal western blot (Figure 1A, B) indicated that both
xCdc4a and xCdc4b are supplied in the egg as maternal
stockpiles, and these would not be affected by this anti-
sense strategy.
xCdc4 is a member of the F-box E3 ligase family, and
as such, requires an intact F-box to interact with the
rest of the SCF complex to target proteins for proteoly-
sis. Deletion of the F-box allows substrate binding but
prevents recruitment to the ubiquitination machinery,
and this strategy has been successfully used many times
to create a dominant negative construct (for example,
[9,39]), whose overexpression results in specific
substrate hyper-stability. Therefore, we used an F-box
deleted dominant negative form of xCdc4 to block the
function of endogenous xCdc4 protein.
Cyclin E overexpression in X. laevis embryos results in
a loss of DNA at early cleavage stages. This leads to a
reduction in the rate of cell cleavage, followed by apop-
tosis of the affected cells at mid-gastrulation [40]. To
determine whether xCdc4a and xCdc4b could both act
as E3 ligases for Cyclin E in vivo, and to demonstrate
that xCdc4ΔFbox has lost this activity, we compared
their ability to inhibit Cyclin E-mediated apoptosis after
micro-injection into X. laevis embryos, as compared
with the anti-apoptotic protein BclXL. As expected,
injection of Cyclin E either alone or with green
Figure 4 xCdc4 is found in ectodermal and mesodermal derivatives. (A-L) xCdc4 ISH on transverse sections of stage 15, 18 and 22 embryos
(A,B,G-I), including sense control (E,F,J-L) and comparative Snail2 expression on stage 15 (C) and stage 18 (D) embryo sections. xCdc4 expression
is detected in the neural crest (NC, black arrows), preplacodal ectoderm (ppe) and neural plate border (NPB) as well as in the neural plate (np).
In addition to the expression in both superficial and deep layers of the ectoderm, there is also expression of xCdc4 in the notochord (n) and in
somitogenic mesoderm (sm).
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of blastomere cleavage detectable at stage 9, followed by
apoptosis at mid-gastrulation stage 11 (Figure 5B, H).
Co-injection of Cyclin E and BclXL resulted in the
appearance of larger blastomeres, but these failed to
undergo apoptosis later, as expected (Figure 5E, K).
Injection of both xCdc4a and xCdc4b along with Cyclin
E suppressed the number of embryos with enlarged cells
and largely prevented apoptosis (Figure 5A, C, D, I, J),
while xCdc4aΔFbox and xCdc4bΔFbox proteins were
ineffective at suppressing these phenotypes (Figure 5A,
F, G, L, M). Thus, xCdc4a and xCdc4b can act as E3
ligases in vivo when overexpressed and require the F-
box for this function.
Cdc4 is thought to target only a phosphoform of
Cyclin E for destruction [35-38]. To look directly at the
effect of xCdc4 on degradation of Cyclin E protein by
western blot, 1 ng of RNA encoding amino-terminal
FLAG Cyclin E was injected into fertilized eggs along
with mRNAs encoding xCdc4 (using the a isoform) or
GFP, as an injection control (Figure 6), and embryos
were allowed to develop to stage 10.5. Embryo lysates
were prepared and immunoblotting was performed to
detect the FLAG epitope on Cyclin E.
Cyclin E migrated as multiple bands in GFP-injected
embryos (Figure 6A, lane 2), and these are likely to be
phospho-forms of the protein [41]. When co-injected
with Cyclin E mRNA, xCdc4 expression resulted in a
r e d u c t i o ni nt h ea b u n d a n c eo fp r e d o m i n a n t l yt h e
slower-migrating phospho-forms of Cyclin E protein
(Figure 6A, lane 3). Densitometry analysis, normalizing
to actin expression in the same samples, confirmed that
phosphorylated forms of Cyclin E are degraded by
xCdc4. This is in agreement with previous results,
which demonstrated a requirement for Cyclin E phos-
phorylation to direct Cdc4-mediated degradation
[9,38,42]. These results verify that xCdc4 is functionally
orthologous to mammalian Cdc4 in its ability to degrade
phospho-forms of Cyclin E.
To confirm that the F-box deletion mutant of xCdc4
(xCdc4ΔFbox) possessed dominant negative activity, its
ability to inhibit Cyclin E degradation mediated by wild-
type xCdc4 was assessed. Cyclin E mRNA was co-
injected with xCdc4 along with one of the following:
xCdc4ΔFbox, xSkp2ΔFbox, an F-box mutant of the
related SCF E3 ligase Skp2, or GFP (Figure 6A, lanes 2
to 5). As expected, overexpression of either xSkp2ΔFbox
or GFP had no effect on phospho-Cyclin E degradation
by xCdc4. In contrast, degradation of Cyclin E by xCdc4
was inhibited by co-injection of xCdc4ΔFbox (lane 5),
confirming that this mutant acts as a dominant negative
form of xCdc4 in the embryos. When phospho-Cyclin E
levels were normalized to the levels in embryos injected
with Cyclin E and GFP, xCdc4 and GFP co-injection led
Figure 5 xCdc4a and xCdc4b block Cyclin E-mediated apoptosis, and this requires an intact F-box domain. Cyclin E mRNA (1 ng) was
co-injected with 1 ng of other mRNAs as indicated into one cell of two-cell-stage embryos. (A) Embryos were scored for enlarged cells at stage
9 and apoptotic cells at stage 11 (n = 75-196). (B-M) Representative embryos from each injection are shown; enlarged cells are highlighted with
white arrows (B,E-G,K) and shown enlarged in insets. Black arrows highlight apoptotic cells (H,L,M).
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xCdc4 was co-injected with xSkp2ΔFbox, a similar
reduction in Cyclin E levels was observed (70%). How-
ever, coexpression of xCdc4ΔFbox with xCdc4 partially
rescued the degradation of Cyclin E. On average, there
was a 30% reduction in Cyclin E levels compared to
Cyclin E- and GFP-injected embryos. In addition, we
also found that xCdc4 targeted endogenous Cyclin E for
degradation (data not shown), again predominantly
reducing the slower-migrating phospho-form of the
protein.
At these early developmental stages, Cyclin E is
expressed throughout the ectoderm [43], so may act as
a target for xCdc4. Since Cdc4 is known to regulate the
stability of other proteins that regulate cell proliferation
(for a review, see [10]), we investigated whether xCdc4
modulated cell cycle progression in the early embryo.
As xCdc4a and xCdc4b share the same substrate bind-
ing regions, xCdc4bΔFbox (hereafter known as
xCdc4ΔFbox) would be expected to inhibit the activity
of both xCdc4 isoforms, and was used throughout in
this study. Indeed, xCdc4aΔFbox gave similar results to
xCdc4bΔFbox (data not shown).
xCdc4ΔFbox does not affect cell cycle in the embryonic
ectoderm
To investigate the effect of xCdc4 activity on cell pro-
liferation, mRNA encoding xCdc4b or xCdc4ΔFbox
was injected unilaterally into two-cell-stage embryos
with GFP mRNA injected as a control. Whole mount
staining using an antibody against phosphorylated his-
tone H3 (phH3) was used to examine the number of
mitotic cells [44]. No change in the number of mitotic
cells in the neural folds was observed following overex-
pression of xCdc4ΔFbox or xCdc4 (Figure 7). To quan-
tify this, the number of mitotic cells in the neural folds
was counted on the injected and uninjected sides, and
the percentage difference was calculated for each
embryo. The average percentage change for
xCdc4ΔFbox (-2.8 ± 3.9%) and xCdc4 (-9 ± 1.2%) over-
expression was not significantly different from that
found after GFP overexpression (-8.3 ± 1.5%, n = 84 to
91). Therefore, overexpression of xCdc4ΔFbox did not
perturb the cell cycle. Indeed, we saw no difference in
the size of the blastomeres on the injected versus the
uninjected side of the embryo (data not shown and
Figure 7), confirming this conclusion.
Figure 6 Phosphorylated Cyclin E protein is degraded by xCdc4. (A) Two-cell-stage embryos were injected with 1 ng of amino-terminally
FLAG-tagged Cyclin E mRNA (lanes 2 to 5) and either 1 ng of GFP mRNA (lane 2) or 1 ng of xCdc4 mRNA (lanes 3 to 5). The ability of
xCdc4ΔFbox to block Cyclin E degradation was examined by co-injecting 1.5 ng of xCdc4ΔFbox mRNA (lane 5), with 1.5 ng of GFP mRNA or 1.5
ng of Skp2ΔFbox mRNA as controls (lanes 3 and 4). Embryos were allowed to develop to stage 10.5 and immunoblotting was performed for the
FLAG epitope, while immunoblotting of actin was performed as a loading control. IR-Dye™-conjugated secondary antibodies were used,
enabling accurate quantification of Cyclin E and actin expression. (B) The level of phospho-Cyclin E was normalized to the level of actin, then
compared to the level of phospho-Cyclin E in GFP-injected embryos, showing mean ± standard error of the mean from four independent
experiments.
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xCdc4 is expressed prominently in the neural crest
throughout early development (Figures 1 and 2). In
order to examine the effect of inhibition of xCdc4 on
neural crest development, xCdc4ΔFbox was overex-
pressed in developing embryos and compared to xCdc4
and GFP injections as controls. After injection of
mRNAs into one cell of two-cell embryos, and subse-
quent development to neural plate stage 15, whole
mount ISH for the neural crest markers Snail2, Snail
and c-Myc were performed. Overexpression of
xCdc4ΔFbox inhibited formation of the neural crest as
measured by decreased Snail2 and Snail expression (Fig-
ure 8A, D), while wild-type xCdc4 and GFP had very lit-
tle effect (Figure 8B, C, E, F). In addition, c-Myc,av e r y
early marker of neural crest [28], was also reduced by
xCdc4ΔFbox (Figure 8G), but not by xCdc4 or GFP
(Figure 8H, I).
To quantify the reduction in expression of neural crest
markers brought about by overexpression of
xCdc4ΔFbox, the area of staining of Snail2, Snail and c-
Myc on the injected side of each embryo was measured
and expressed as a ratio of the area on the uninjected
side. A ratio less than 1 indicated a reduction in staining
on the injected side compared to the uninjected side.
The mean ratio was then calculated for at least two
independent experiments, and compared with the ratio
for GFP-injected embryos (which had minimal effect).
Overexpression of xCdc4ΔFbox blocked neural crest
development, as determined by expression of Snail2,
Snail and c-Myc, resulting in an average 57% reduction
in Snail2 staining on the injected side of the embryo,
compared with embryos injected with GFP alone. Over-
expression of xCdc4 had essentially no effect on Snail2
staining (n = 58 to 122). Similarly, overexpression of
xCdc4ΔFbox reduced Snail and c-Myc staining on the
injected side of the embryo by 80% and 67% respec-
t i v e l y ,w h e nc o m p a r e dt oe mbryos injected with GFP
alone (n = 30 to 52 for both).
T oc o n f i r mt h a tx C d c 4 ΔFbox was acting as a domi-
nant negative, we determined whether co-injection with
wild-type xCdc4 could rescue the reduction in neural
crest. In this experiment, xCdc4ΔFbox significantly
reduced Snail2 and Snail expression in 34% and 67% of
embryos, respectively, compared to only 12% and 6%,
respectively, when the wild-type xCdc4 was co-injected
with xCdc4ΔFbox (n = 18 to 21; Figure 9). This rescue
demonstrates that xCdc4ΔFbox can act as a dominant
n e g a t i v ei nt h ep r e s e n c eo fw i l d - t y p ex C d c 4 .I n d e e d ,a s
endogenous xCdc4 is likely to be expressed at a much
lower concentration than that expressed from micro-
injected mRNA, xCdc4ΔFbox is likely to be much more
effective at inhibiting the endogenous xCdc4 protein.
As our sections revealed rather broad expression of
xCdc4 in ectodermal and mesodermal derivatives, we
investigated whether xCdc4ΔFbox affected patterning
and/or specification of other tissues. We saw that ante-
rior-posterior patterning and mesoderm development of
the embryos were unaffected by overexpression of either
wild-type xCdc4 or xCdc4ΔFbox, as determined by
Otx2, Engrailed2, Krox20, MyoD, Heavy chain myosin
(HCM)a n depidermal keratin expression (Additional
files 2 and 3). Moreover, Sox2, a marker of neural plate
neuronal precursors, and Neural beta-tubulin (NbT), a
marker of neuronal differentiation, were also unaffected
(Figure 8S; Additional file 3). This suggested that the
effect of xCdc4ΔFbox overexpression on neural crest
development was not dependent on either early pattern-
ing events or secondary effects resulting from induction
of mesoderm, and was indeed specific to the neural
Figure 7 xCdc4ΔFbox does not affect the cell cycle. xCdc4ΔFbox or xCdc4 mRNA (1 ng) was injected into one cell of two-cell-stage embryos.
GFP mRNA (1 ng) was injected as a control, and b-gal mRNA was injected as a lineage tracer (light blue unilateral staining). Whole mount
antibody staining against phH3 was performed to detect mitotic cells. The average percentage difference in the number of mitotic cells on the
injected side, compared to the uninjected side, was calculated as indicated in Materials and methods. Representative embryos are shown
(anterior view, dorsal up, injected side right).
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Skp2ΔFbox mutant had no effect on Snail2 expression
(Additional file 4).
We investigated whether xCdc4 activity was required
for expression of other regulators of neural crest forma-
tion lying upstream of Snail2 and Snail (Figure 8). At
stage 15, Pax3 (53%) and Msx1 (100%) showed signifi-
cant reduction in the presence of xCdc4ΔFbox but not
wild-type xCdc4, indicating that xCdc4 plays a broad
role in controlling expressi o no fr e g u l a t o r so fn e u r a l
crest. Interestingly, xCdc4ΔFbox inhibited neural crest
expression of Opl in some embryos (62%), but did not
have a significant effect on its placodal expression (Fig-
ure 8M). This is supported by the failure of
xCdc4ΔFbox to affect the expression of the placodal
marker Six1 (Additional file 5). Thus, xCdc4 does not
play an essential role in specification of all the tissues in
which it is expressed, but does have an essential role in
formation of the neural crest.
xCdc4 is expressed broadly and diffusely before stage
15, and while expression is seen in other tissues, tran-
scripts concentrate in the placodes and neural crest
derivatives as the neural tube closes (Figures 1, 2, and
4). The first signs of neural crest specification occur ear-
lier, so we investigated whether xCdc4 was required for
establishment or maintenance of neural crest identity.
To this end, we investigated the effect of xCdc4ΔFbox
expression on earlier marker expression in the prospec-
tive neural crest (Figure 10). After overexpression of
xCdc4ΔFbox, we saw a reduction in Snail2 (44%; n =
32) and Snail (58%; n = 26) expression by stage 13/14
that was not seen with the wild-type protein (both 100%
no significant reduction; n = 25 and n = 35, respec-
tively), indicating that xCdc4 has a role early in neural
crest specification, and is not solely required for its
maintenance.
To determine the effect of inhibiting xCdc4 on later
neural crest derivatives, we allowed embryos injected in
both dorsal cells of four-cell-stage embryos to develop
until stage 43, and then investigated the differentiation
of melanocytes and formation of cartilage, both neural
crest-derived tissues. We saw that embryos injected with
GFP had a normal number and distribution of melano-
cytes. In contrast, after injection of xCdc4ΔFbox,
embryos showed significant reduction and an abnormal
distribution of melanocytes (Figure 11; n = 31 to 57, P
<< 0.0001)) compared with the GFP-injected controls. A
much smaller decrease in the number of melanocytes
was also observed following injection with xCdc4 when
compared with the GFP control (P < 0.01). As
xCdc4ΔFbox-injected embryos looked abnormal, with a
significant reduction of head morphology, we examined
the effect of xCdc4ΔFbox on cartilage formation by
staining the embryos with alcian blue. We found that
most xCdc4ΔFbox-injected embryos showed compacted
head cartilage with weaker cartilage staining compared
to xCdc4- or GFP-injected embryos (data not shown).
W ea l s on o t e dt h a te m b r y o st h a tw e r ee x p r e s s i n g
xCdc4ΔFbox show other developmental abnormalities,
including oedema and a high frequency of reduced eyes
( F i g u r e1 1 A ) .T h e s ep h e n o t y p e s ,w h i c hw eh a v en o t
been characterized further, may be secondary to loss of
neural crest or may result from a later requirement of
Figure 8 xCdc4ΔFbox inhibits neural crest development.
xCdc4ΔFbox or xCdc4 mRNA (1 ng) was injected into one cell of
two-cell-stage embryos. GFP mRNA (1 ng) was injected as a control,
and b-gal mRNA was injected as a lineage tracer (light blue or red
unilateral staining). (A-U) Whole mount ISH was performed for
Snail2 (A-C), Snail (D-F), c-Myc (G-I), Pax3 (J-L), Opl (M-O) and Msx1
(P-R), and the early neuronal marker Sox2 (S-U). Representative
embryos are shown (anterior view, dorsal up, injected side right).
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Page 10 of 20Figure 9 Loss of neural crest induced by xCdc4ΔFbox is rescued by co-injection of xCdc4. xCdc4ΔFbox mRNA (1 ng) was co-injected with
either 1 ng of xCdc4 or 1 ng of GFP mRNA into one cell of two-cell-stage embryos. As controls, 1 ng of xCdc4 mRNA was co-injected with 1 ng
of GFP mRNA, as well as injection of 2 ng of GFP mRNA as a separate control. b-gal mRNA was injected as a lineage tracer. (A-H) Embryos were
allowed to develop to stages 18/19 and whole mount ISH was performed for the neural crest markers Snail2 (A-D) and Snail (E-H).
Representative embryos are shown (anterior view, dorsal up, injected side right). Arrows indicate loss of expression of each marker on the
injected side of xCdc4ΔFbox expressing embryos. The reduction in expression of each marker on the injected side of xCdc4ΔFbox expressing
embryos is rescued by co-injection of xCdc4 mRNA (arrowheads).
Figure 10 xCdc4ΔFbox inhibits neural crest specification.x C d c 4 ΔFbox or xCdc4 mRNA (1 ng) was injected into one cell of two-cell-stage
embryos. GFP mRNA (1 ng) was injected as a control, and b-gal mRNA was injected as a lineage tracer (light blue unilateral staining). (A-F)
Embryos were allowed to develop to stage 13/14 and the expression of Snail2 (A-C) and Snail (D-F) in the prospective neural crest region was
examined by whole mount ISH. Representative embryos are shown (anterior view, dorsal up, injected side right). Arrows indicate loss of
expression of each marker on the injected side of xCdc4ΔFbox expressing embryos.
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example, the eye field (Figure 1I). As injected mRNA is
not thought to persist much beyond tailbud stages,
these defects most likely resu l tf r o mar e q u i r e m e n tf o r
xCdc4 at these earlier stages.
Since xCdc4ΔFbox did not result in an increase in
cycling cells that could disrupt neural crest differentia-
tion, we investigated the possibility that xCdc4ΔFbox
results in apoptosis of cells destined to become neural
crest. TUNEL (terminal deoxynucleotidyltransferase-
mediated dUTP-biotin nick end labeling) staining was
used to detect apoptotic cells following mRNA injection.
No difference in TUNEL staining was observed follow-
ing overexpression of xCdc4ΔFbox (Figure 12A-D).
Approximately 70% of embryos had TUNEL positive
cells (n = 100 to 110), but in no case were differences in
TUNEL staining observed, either in the neural folds or
in the embryo as a whole.
We were surprised at the low frequency of TUNEL-
positive cells detected in this assay, although embryos
that had been wounded were used as a positive control
and were highly TUNEL-positive (data not shown).
Therefore, an alternative assay for apoptosis was also
used. We took advantage of the fact that hBclXL can
block apoptosis in X. laevis [19,40]. We checked
whether Snail2 expression in xCdc4ΔFbox injected
embryos could be rescued by co-expression of hBclXL.
xCdc4ΔFbox, xCdc4 or GFP (1 ng) were injected unilat-
erally into two-cell-stage embryos. In addition, 1 ng of
hBclXL or GFP were co-injected as appropriate. Whole
mount ISH for Snail2 was performed on stage 18
embryos, and Snail2 staining in xCdc4ΔFbox/hBclXL-
Figure 11 xCdc4ΔFbox impairs melanocyte development. xCdc4ΔFbox, xCdc4 or control GFP mRNA (0.5 ng) were injected into each of the
two dorsal cells of four-cell-stage embryos. (A-C)Embryos were allowed to develop to stage 43 and subsequently the distribution and number of
melanocytes were compared: xCdc4ΔFbox (A), xCdc4 (B) and GFP (C). (A-C) Representative embryos are shown (lateral views, anterior side right).
(D)The average number of melanocytes for each condition was calculated and the mean ± standard error of the mean from two independent
experiments are shown (n = 31 to 57). There was a significant decrease in the number of melanocytes following injection with xCdc4ΔFbox
when compared to GFP or xCdc4 (***P << 0.0001), and a smaller decrease following injection with xCdc4 when compared to injection with GFP
(*P < 0.01).
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Page 12 of 20Figure 12 xCdc4ΔFbox does not reduce neural crest by inducing apoptosis. (A,B) xCdc4ΔFbox or xCdc4 mRNA (1 ng) was injected into
one cell of two-cell-stage embryos. (C) GFP mRNA (1 ng) was injected as a control, and b-gal mRNA was injected as a lineage tracer (light blue
unilateral staining). Apoptosis was assessed using TUNEL staining. Arrow indicates TUNEL-positive cells. Representative embryos are shown
(anterior view, dorsal up, injected side right). (D) The area of Snail2 staining on the injected side was expressed as a ratio of the area on the
uninjected side, and for each experiment an average ratio was obtained (see Materials and methods). Mean ± standard error of the mean ratio
from two independent experiments are shown (n = 57-82). (E-J) xCdc4ΔFbox, xCdc4 or GFP mRNA (1 ng) was injected into one cell of two-cell-
stage embryos, along with 1 ng of hBclXL or 1 ng of GFP mRNA as indicated, with b-gal mRNA as a lineage tracer (light blue unilateral staining).
Whole mount ISH for Snail2 was performed on stage 18 embryos. The reduction in expression of Snail2 on the injected side of xCdc4ΔFbox
expressing embryos is not rescued by co-injection of hBclXL (arrowheads). Representative embryos from the indicated injections are shown
(anterior view, dorsal up, injected side right).
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injected embryos (n = 57 to 82; Figure 12E-J). In these
experiments, xCdc4ΔFbox/GFP-injected embryos dis-
played an average 32% reduction in Snail2 staining,
compared to GFP-injected embryos (mean ± SEM ratios
were 0.66 ± 0.05 and 0.97 ± 0.02, respectively). How-
ever, no rescue of Snail2 staining was seen when
hBclXL was co-injected with xCdc4ΔFbox, with an aver-
age 41% reduction in Snail2 staining on the injected
side compared to embryos injected with GFP/hBclXL.
Thus, loss of neural crest after inhibition of xCdc4 activ-
ity is not due to tissue loss by apoptosis.
In summary, we have identified two homologues of
Cdc4 in X. laevis that show dynamic expression in the
early embryo, in particular in the developing neural
crest and its derivatives. While unexpectedly having no
effect on cell cycling, blocking xCdc4 function by over-
expression of a dominant negative form of the protein
resulted in inhibition of specification and formation of
the neural crest. This had long-term consequences for
the formation of neural crest derivatives such as mela-
nocytes and cartilage. Thus, regulated and specific pro-
teolysis by xCdc4 plays an essential function in early
development distinct from its well-established role in
regulating cell division.
Discussion
This work has identified a novel role for the F-box pro-
tein xCdc4 in neural crest development in X. laevis.
Cdc4 orthologs in vertebrates have attracted consider-
able interest due to the plethora of substrates they
degrade, and the fact that Cdc4 is a haplo-insufficient
tumor suppressor protein [10,16]. However, the embryo-
nic lethality of Cdc4 knock-out mice precluded a
detailed analysis of the role of this protein in develop-
ment [17].
X. laevis Cdc4 is likely to be orthologous to vertebrate
Cdc4 for several reasons. Firstly, xCdc4 is highly con-
served compared to human Cdc4, both in terms of
sequence and apparent gene organization. Secondly,
xCdc4a and xCdc4b are capable of degrading Cyclin E,
a known substrate of mammalian Cdc4. This validates
the use of X. laevis to study the developmental function
of Cdc4. In contrast, recovered Cdc4
-/- mouse embryos
show profound vascular defects [17], precluding study in
other developmental processes. Developing amphibian
embryos do not require a functional vasculature until
later embryonic stages, making this an excellent system
for studying other functions of Cdc4.
In this work, we report the isolation of two xCdc4 iso-
forms, xCdc4a and xCdc4b. The genes encoding them
are almost identical from the region corresponding to
the second exon (1,622 out of 1,625 nucleotides identi-
cal). This strongly suggested that the structure of the
Xenopus gene was conserved compared to mammals. In
humans and mice, the Cdc4 locus encodes three iso-
forms of Cdc4; designated a, b and g.T h e s ea r ep r o -
duced by alternative splicing of three unique 5’ exons to
ten common 3’ exons, yielding proteins that differ only
at their amino termini. Although our data suggest that
this gene structure is preserved, no xCdc4g isoform was
detected during this work. In addition, in silico analysis,
using the Ensembl genome browser, failed to detect
sequences corresponding to the g specific exon.
To check if xCdc4 was functionally orthologous to
vertebrate Cdc4, the ability of xCdc4 to degrade Cyclin
E was examined. xCdc4 overexpression reduced the
abundance of Cyclin E, compared to embryos co-
injected with GFP, preferentially reducing the abun-
dance of the slower migrating hyper-phosphorylated
form of Cyclin E (Figure 6A). This is in agreement with
previous findings that Cdc4 only interacts with phos-
phorylated Cyclin E [35-38]. xCdc4 also degrades Cyclin
E in vivo, while xCdc4ΔFbox does not (Figure 6).
The spatio-temporal expression of xCdc4 was exam-
ined by immunoblotting for xCdc4 isoforms, and by
whole mount ISH (Figure 1). Using antibodies that
detected xCdc4, both isoforms were expressed at all
stages tested. xCdc4a migrated at an apparent molecular
weight of 100 kDa, despite having a predicted molecular
weight of 79 kDa (Figure 1A). This is in keeping with a
previous report that showed that human Cdc4a
migrated with an apparent molecular weight of 110 kDa,
although its predicted molecular weight was 80 kDa [9].
In contrast, xCdc4b consistently migrated slightly faster
than its predicted molecular weight of 62 kDa (Figure
1B).
Although expressed across the embryo, the neural
crest and placodes were the first sites where xCdc4 tran-
scripts accumulated most prominently (Figures 1, 2 and
4). Subsequently, transcripts were detected in the bran-
chial arches and fin mesenchyme, which are both neural
crest derived tissues, as well as in the somites and brain,
and co-localized in many areas with other known mar-
kers of neural crest and placodes (Figures 1 and 2). In
order to examine the function of xCdc4 during develop-
ment, gain and loss of function experiments were per-
formed. Translation-blocking morpholinos did not
inhibit expression of endogenous xCdc4a and xCdc4b
(data not shown). One possible explanation for this was
the maternal expression of the proteins. Therefore, an
F-box deletion mutant was used as an alternative way to
inhibit the function of xCdc4. xCdc4ΔFbox acted as a
dominant negative inhibitor of xCdc4’sa b i l i t yt o
degrade Cyclin E (Figure 6) because it retains its ability
to bind to substrate but cannot recruit the substrate
to the rest of the SCF complex. The specificity of F-
box proteins resides in their substrate binding site, and
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substrate but not to the Skp1 component of the SCF E3
ligase complex, have been widely employed as reagents
to block degradation of specific F-box targets. Confirm-
ing this, xSkp2ΔFbox did not inhibit xCdc4-mediated
degradation of the protein. As xCdc4 is expressed
strongly in the neural crest, we investigated the effect of
overexpression of xCdc4ΔFbox on development of this
tissue.
Inhibition of xCdc4, using xCdc4ΔFbox, inhibited
neural crest development, as determined by Snail2 and
Snail ISHs (Figures 8, 9 and 10). This inhibition of
neural crest development occurred at an early stage,
upstream of c-Myc, reducing expression of a number of
proteins acting as regulators of Snail2, Snail and c-Myc
(Figure 8). This indicates that xCdc4 is required for
establishment of neural crest identity, rather than simply
maintenance of that identity. Although expressed more
broadly in ectodermal and mesodermal derivatives, we
did not detect a requirement for xCdc4 function in spe-
cification or differentiation of other tissues, nor in pat-
terning of the neural tube (Additional files 2, 3 and 5),
strongly indicating a tissue-autonomous role in the
neural crest.
The most well characterized role of Cdc4 is in regulat-
ing the cell cycle, and we investigated whether xCdc4
regulates cell cycling in the early X. laevis embryo.
xCdc4ΔFbox overexpression did not perturb the cell
cycle as determined by phH3 staining in these early
embryos (Figure 7). The results from phH3 staining are
consistent with previous observations that cell prolifera-
tion has a minor role in neural crest development;
neural and neural crest induction has been reported to
proceed normally when cell division was blocked from
mid-gastrula stages onwards [19,45].
xCdc4ΔFbox does not inhibit neural crest develop-
ment through activation of an apoptotic program. The
evidence for this is threefold: xCdc4ΔFbox overexpres-
sion did not lead to a loss of b-gal staining expressed
from co-injected mRNA; there was no change in
TUNEL staining (Figure 12A-D); and finally, co-injec-
tion of hBclXL did not affect the ability of xCdc4ΔFbox
to block neural crest development (Figure 12E-J). X. lae-
vis embryos can undergo apoptotic cell death from stage
10.5 onwards [46-48]. TUNEL analysis during embryo-
nic development showed that only 50 to 60% of embryos
had TUNEL-positive cells in the ectoderm prior to stage
18 [49]. After this stage a higher percentage of embryos
were TUNEL-positive, but individual embryos displayed
less TUNEL staining. In terms of neural crest develop-
ment, Sox10 and Id3 depletion have been reported to
increase TUNEL staining in the neural crest, but this
was coupled to a reduction in cell proliferation [50,51].
However, it has been reported that inhibition of the cell
cycle reduces clearance of apoptotic cells, meaning that
cell cycle inhibition in these embryos may have led to
increased TUNEL staining [52].
Previous studies have reported increased levels of
apoptosis occurring in neural folds rather than other
areas of the embryonic ectoderm [47,49,53], and a num-
ber of genes involved in neural crest development pos-
sess anti-apoptotic activity (for example, [53,54]). It is
possible that apoptosis regulates neural crest develop-
ment in a stage-specific manner. For example, it may be
important in defining the neural crest boundary, rather
than for neural crest induction. However, as xCdc4 acts
at an early stage of neural crest development, regulation
of apoptosis may not be involved.
The identification of Cdc4 as a regulator of neural
crest development adds to existing evidence that the
ubiquitin proteasome system plays a role in the develop-
ment of this tissue. Overexpression of dominant nega-
tive Cullin1, which is predicted to inhibit all SCF E3
ligases, expanded the neural crest in X. laevis.T h i sw a s
primarily due to stabilization of the Wnt pathway com-
ponent b-catenin, although other substrates are likely to
have been involved [55]. Recently, the F-box protein Ppa
was shown to regulate neural crest development by
degradation of Snail2 in X. laevis. Overexpression of Ppa
inhibited neural crest development [26]. The related
protein Snail is degraded by the F-box protein b-TRCP
in tissue culture cells [56]. Thus, a number of proteins
involved in neural crest development display dynamic
expression patterns, and regulation by ubiquitin-
mediated proteolysis is emerging as a method to achieve
this through activity of different E3 ligases that target
distinct substrates.
What substrates is Cdc4 targeting to influence neural
crest formation? c-Myc regulates neural crest develop-
ment [19,57] and can be degraded by Cdc4 [11,29], but
we saw that xCdc4ΔFbox decreased c-Myc mRNA (Fig-
ure 8), indicating that xCdc4 also acts upstream of c-
Myc expression. Indeed, xCdc4 acts upstream of early
regulators of neural crest, such as Pax3 and Msx1 (Fig-
ure 8). We hypothesized that xCdc4 was degrading a
negative regulator of neural crest development. c-Jun is
another known target of Cdc4 [12] and is expressed at
the right time and place to be regulating neural crest
formation, although its exact role is poorly understood
[58,59]. We saw that overexpression of c-Jun did indeed
inhibit Snail2 expression (Additional file 6). However,
when we tested whether xCdc4 could target c-Jun pro-
tein for degradation in embryos by co-injection of
mRNAs encoding these proteins, and performing immu-
noblotting against HA-tagged c-Jun, we saw no effect of
xCdc4 on c-Jun levels (data not shown). From these
results, it is not clear whether c-Jun is a target for Cdc4
in this developmental context, and in any case, an
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tion in X. laevis has not been clearly demonstrated.
Identification of E3 ligase targets is challenging, and
co-factors required for protein degradation may be
active only in certain contexts. For example, it has been
noted that Cdc4-mediated degradation of c-Jun in tissue
culture cells required co-expression of Glycogen
synthase kinase 3b (GSK3b) [60]. It will be important to
now identify the in vivo targets of Cdc4 that regulate
formation of the neural crest if we are to have a fuller
understanding of the role of selective protein degrada-
tion in the development of this tissue.
Conclusions
Here we identify xCdc4 as a novel regulator of neural
crest development in X. laevis, acting early in neural
crest formation, potentially by regulation of c-Jun. These
results demonstrate that Cdc4’s role as a tumor suppres-
sor protein may extend beyond its ability to regulate the
cell cycle to an ability to directly regulate tissue
differentiation.
Materials and methods
Plasmids and constructs
Expression of constructs was verified by immunoblotting
embryo lysates after microinjection of capped mRNA.
X. laevis Cdc4b (xCdc4b) was cloned by PCR from
stage 20 cDNA. Primers used to obtain the full length
coding sequence were: forward, 5’-ATGGGCTTC-
TACGGCAC-3’; reverse, 5’-CCTTCACTTCATGTC-
CACGTC-3’. xCdc4b was cloned into pCS2+repaired to
synthesize capped mRNA for microinjection. An F-box
deletion mutant of xCdc4b (xCdc4bΔFbox)w a sp r o -
duced by PCR and triple ligation strategy. The F-box
region of xCdc4b (nucleotides 379 to 516 inclusive) was
replaced with an AseI site (ATTAAT, amino acids Ile
and Asn).
Primers 5’-GCAACCGAATTCACCACCATGGGCTT
CTACGGCAC-3’ and 5’-GGTTGCATTAATAAAGT
CCCGCTGAAACTGG-3’ were used to amplify xCdc4b
upstream of the F-box, and 5’-GCAACCATTAATGAA-
GATGGGATCGATGAGC-3’ and 5’-GGTTGCCTCGA
GTCACTTCATGTCCACGTC-3’ were used to amplify
xCdc4b downstream of the F-box.
X. laevis Cdc4a (xCdc4a) was similarly cloned using
cDNA derived from stage 7 embryos. Primers used to
obtain the full length coding sequence were: forward, 5’-
GCTGGCTTTTGGAAATGAATCAGG-3’; reverse, 5’-
CTTCACTTCATGTCCACATCAAAGTCC-3’. xCdc4a
was cloned into pGEM-T Easy (Promega, Madison, WI,
USA) downstream of the SP6 promoter. The GenBank
accession number is DQ666345. A single point mutation
was introduced into this sequence (nucleotide G1946A
in the coding sequence, resulting in G649D in the
protein), to introduce an Asp residue that is conserved
amongst vertebrates, to correct what was likely a cloning
error; xCdc4a (G) was much less potent at inhibiting
formation of neural crest compared to xCdc4a (D) (data
not shown). XCdc4a (D) also degraded Cyclin E more
efficiently than xCdc4a (G) (data not shown). Site direc-
ted mutagenesis was performed using a QuikChange®
Multi Site Directed Mutagenesis kit (Stratagene, La
Jolla, California) according to the manufacturer’s
instructions. xCdc4aΔFbox was produced by an identical
method to that described for xCdc4bΔFbox. X. laevis
Skp2ΔFbox has been described elsewhere [39].
X. laevis c-Jun in pCS2+ (GenBank accession number
AJ243954) was a kind gift of Professor Walter Knochel
(Institute of Biochemistry, University of Ulm, Germany).
Antibodies
Anti-Cdc4 monoclonal antibodies (3B7 and 3A9) were a
kind gift from Dr Axel Behrens (CRUK). Anti-FLAG
M2 conjugated to horse radish peroxidase (A8592; used
at 1:1,000), anti-tubulin B512 (T5168; used at 1:2,000)
and anti-rabbit IgG conjugated to alkaline phosphatase
(A9919; used at 1:1,000) were from Sigma (St Louis,
MO, USA). Horse radish peroxidase conjugated anti-
rabbit and mouse IgG (NA943 and NA931; used at
1:5,000) were from Amersham (GE Healthcare, Uppsala,
Sweden), rabbit anti-phH3 (06570; used at 1:1,000) was
from Upstate (Millipore, Billerica, MA, USA) and alka-
line phosphatase conjugated anti-digoxigenin fab frag-
ments (11093274910; used at 1:5,000) were from Roche
(Basel, Switzerland).
Xenopus laevis embryo manipulation
X. laevis embryos were obtained by hormone-induced egg
laying and in vitro fertilization by standard methods. Uni-
lateral injections into the animal pole of two-cell-stage
embryos (unless otherwise indicated) were carried out
with in vitro transcribed capped mRNA (Ambion, Austin,
TX, USA). mRNA was injected at doses of up to 2 ng in a
volume of 10 nl, and 0.5 ng of b-gal mRNA was co-
injected as a lineage tracer. GFP mRNA was injected as a
control. Embryos were staged according to [61] and grown
to the required stage. They were fixed in MEMFA (4% for-
maldehyde, 100 mM MOPS, 2 mM EGTA, 1 mM MgSO4,
pH 7.4), washed in phosphate-buffered saline (PBS)/2 mM
MgCl2, and stained with 1 mg/ml X-gal (5-bromo-4-
chloro-3-indolyl-beta-D-galactopyranoside) in X-gal mixer
(5.35 mM K3Fe(CN)6,5 . 3 5m MK 4Fe(CN)6,1 . 2m M
MgCl2, 0.1% sodium deoxycholate, 0.2% NP-40 in PBS).
Alternatively, embryos were stained with 1.7 mg/ml Red-
gal® (6-chloro-3-indolyl-beta-D-galactopyranoside) in X-
gal mixer. Embryos were washed in PBS, dehydrated in
methanol and stored at -20°C.
In situ hybridization
Whole mount ISH was performed using a BioLane™ HTI
in situ robot (Holle and Huttner (Tubingen, Germany).
Almeida et al. Neural Development 2010, 5:1
http://www.neuraldevelopment.com/content/5/1/1
Page 16 of 20The washes and composition of solutions were as
described in [62], with some modifications in the proto-
col. The RNase step was omitted, and embryos were
blocked with 2% Blocking Reagent (Roche) and 20%
heat inactivated lamb serum in maleic acid buffer. Incu-
bation with 1:5,000 anti-digoxigenin was performed in
t h es a m es o l u t i o n .T h ec o l o rr e a c t i o nw a st e r m i n a t e d
using PBS washes and embryos were re-fixed in
MEMFA. Embryos were bleached as described in [62].
xCdc4 in pBSK+ was linearized with PstIa n dt r a n -
scribed T3 for antisense, and linearized with NotIa n d
transcribed T7 for sense. The following probes were
used: c-Myc, MsxI [53], Opl/Zic1 [32], Pax3 [30], Snail,
Six1 [34], Sox2, Sox10 [31] and Snail2 [25].
To quantify the area of Snail2 expression, Openlab™
software (Improvision/Perkin Elmer, Waltham, MA,
USA) was used to select the area of Snail2 staining on
the injected (I) and uninjected (U) side, using all
injected embryos unless they were damaged. For each
experiment the average ratio of I/U was determined for
each injection to determine the change in Snail2 stain-
ing on the injected side, a ratio of <1 indicating Snail2
reduction. For at least two experiments, a mean ratio ±
standard error of the mean (SEM) for each injection
was calculated by taking the mean of the average ratios,
and a Student’s t-test performed. The ratios were com-
pared to GFP-injected control embryos.
ISH on sectioned embryos was performed as described
in [63]. Stage 15 to 22 embryos were fixed in MEMFA,
embedded in a paraffin and beeswax solution and sec-
tioned using a Leica microtome. The ISH was per-
formed on 14-μms e c t i o n su s i n gxCdc4 and Snail2
probes. The slides were mounted using Aquamount
(BDH-Merck, VWR International, West Chester, PA,
USA).
Whole mount antibody staining
Whole mount antibody staining, using anti-phH3, was
performed as described in [62]. The chromogenic reac-
tion was developed as described, using 0.45 mg/ml
Nitroblue tetrazolium chloride (NBT; Roche) and 0.2
mg/ml 5-bromo-4-chloro-3-indolyl-phosphate (BCIP;
Roche) in alkaline phosphatase buffer.
TUNEL staining to detect apoptotic cells
Embryos were devitellinized, fixed in MEMFA, stained
for b-gal and bleached. They were washed in 1× Term-
inal Deoxynucleotidyl Transferase (TdT) buffer (Invitro-
gen, Paisley, UK); 100 mM potassium cacodylate pH 7.2,
2m MC o C l 2 and 0.2 mM dithiothreitol) and incubated
overnight at room temperature in TdT buffer with 0.5
μM alkaline stable digoxigenin-11-dUTP (Roche) and
150 U/ml recombinant TdT (Invitrogen). The TdT reac-
tion was stopped by washing embryos at 65°C with
PBST (phosphate-buffered saline, 0,1% Tween 20)/1
mM EDTA. Overnight incubation of the embryos in
PBST/20% heat inactivated goat serum with anti-digoxi-
genin was performed at 4°C. Embryos were washed with
PBS, and staining was developed using NBT/BCIP.
Analysis of melanocyte distribution
Embryos were injected with 0.5 ng of xCdc4ΔFbox,
xCdc4 or control GFP mRNA into each of the two ani-
mal dorsal cells of four-cell-stage embryos. At stage 43,
the embryos were fixed in MEMFA and dehydrated
overnight in ethanol. For the examination of melano-
cytes, individual embryos were photographed, the ante-
rior region selected and the number of melanocytes
counted using Image J software. For each condition, the
number of melanocytes was averaged, the mean ± SEM
was calculated and a Student’s t-test performed.
Western blotting
Embryos were lysed in 100 mM NaCl, 5 mM EDTA,
0.1% Triton X-100 and 50 mM b-glycerophosphate.
Cleared supernatants were mixed with an equal volume
of 2× SDS gel loading buffer (100 mM Tris pH 6.8, 4%
SDS, 20% glycerol and 0.2% bromophenol blue), and
dithiothreitol was added to a final concentration of 100
mM. One embryo equivalent per lane was loaded. In
order to quantify protein levels, blots were imaged by
using infrared fluorescence of appropriately tagged sec-
ondary antibodies and quantified by using a LiCOR
Biosciences (Lincoln, Nebraska, USA) Odyssey scanner
and software.
Additional file 1: Alignment of X. laevis Cdc4 isoforms to hCdc4a
and hCdc4b. ClustalW alignment of human (HU) and X. laevis (Xl) Cdc4a
and Cdc4b. Xl Cdc4a shows 88% identity to HU Cdc4a. Similarly, Xl
Cdc4b shows 86% identity to HU Cdc4b. Black boxes denote nuclear
localization signals for Xl and HU Cdc4a; red box indicates F-Box motif;
green boxes outline WD40 repeat region. Domain assignments were
made using the Pfam program at the Sanger Centre [64]. The putative
dimerization domain of Cdc4 (based on [646566] is shown as a black
dashed line. Grey regions indicate identity while blue signifies similar
amino acids. A single point mutation was introduced into xCdc4a
(nucleotide G1946A in the coding sequence, resulting in G649D in the
protein) to introduce an Asp residue (denoted by red text at position
649) that is conserved amongst vertebrates, to correct what was most
likely a cloning error.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1749-8104-5-1-
S1.JPEG]
Additional file 2: xCdc4ΔFbox does not affect anterior-posterior axis
patterning. We injected 1 ng of xCdc4ΔFbox (A,B,E,F,I,J) or xCdc4 mRNA
(C,G,K) into one cell of two-cell-stage embryos; 1 ng of GFP mRNA (D,H,
L) was injected as a control and b-gal mRNA was co-injected as a
lineage tracer. Stage 16 to 18 embryos were stained for the forebrain/
anterior midbrain marker Otx2 (A-D), the midbrain/hindbrain junction
marker En2 (E-H), or the hindbrain marker Krox20 (I-L). Representative
embryos from three independent pooled experiments are shown (n = 38
to 79; anterior view, dorsal up, injected side right). Numbers represent
the percentages of embryos displaying each phenotype and white
arrows highlight differences in expression of the markers on the injected
side.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1749-8104-5-1-
S2.JPEG]
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Page 17 of 20Additional file 3: xCdc4ΔFbox does not affect development of the
myotome, the epidermis or primary neurons. xCdc4ΔFbox, xCdc4 or
control GFP mRNA (1 ng) was injected into one cell of two-cell-stage
embryos. b-gal was co-injected as a lineage tracer. ISH was performed
on stage 13 to 15 embryos for MyoD (A-C) and epidermal keratin (EK)( G -
I), on stage 15 embryos for neural b-tubulin (NbT) (J-L) and at stage 18 to
20 for heavy chain myosin (HCM) (D-F). Representative embryos for the
indicated injection are shown (dorsal view, anterior up, injected side on
the right). Numbers are the percentage of embryos with normal
phenotypes (n = 59 to 109).
Click here for file
[http://www.biomedcentral.com/content/supplementary/1749-8104-5-1-
S3.JPEG]
Additional file 4: The F-box protein xSkp2 does not affect neural
crest development. xSkp2 or xSkp2ΔFbox mRNA (2 ng) was injected
into one cell of two-cell-stage embryos. GFP mRNA (2 ng) was injected
as a control. b-gal mRNA was co-injected as a lineage tracer. ISH for
Snail2 was performed on stage 18 embryos. As an additional control, ISH
was performed in parallel for NbT on stage 15 embryos. (A-C)
Representative embryos (anterior view, dorsal up, injected side on the
right) from Snail2 ISH for each injection. Numbers are the percentage of
embryos displaying each phenotype (pooled data from two experiments;
n = 53 to 61). (D-F) Representative embryos (dorsal view, anterior up,
injected side on the right) injected with the indicated mRNA, from NbT
ISH. Numbers are the percentage of embryos displaying each phenotype
(n = 49 to 52). White arrows indicate reduced primary neurons on the
injected side of the embryo.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1749-8104-5-1-
S4.JPEG]
Additional file 5: xCdc4ΔFbox does not affect placode development.
xCdc4ΔFbox, xCdc4 or control GFP mRNA (1 ng) was injected into one
cell of two-cell-stage embryos. b-gal was co-injected as a lineage tracer.
ISH was performed on stage 16 to 18 embryos for the placodal marker
Six1 (n = 49 to 86). (A-C) Representative embryos are shown for the
indicated injections (dorsal view, anterior up, injected side right).
Numbers represent the percentage of normal embryos.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1749-8104-5-1-
S5.JPEG]
Additional file 6: c-Jun is a negative regulator of neural crest
development. c-Jun mRNA (0.5 ng or 1 ng) was injected into one cell of
two-cell-stage embryos. GFP mRNA was injected as a control, and b-gal
mRNA was injected as a lineage tracer (light blue unilateral staining).
Whole mount ISH was performed for Snail2 (A-C) or c-Myc (D-F)
expression. The area of Snail2 staining on the injected side was
expressed as a ratio of the area on the uninjected side. The mean ± SEM
ratio (n = 37 to 87) is shown for each injection. Representative embryos
are shown (anterior view, dorsal up, injected side right). The average
percentage reduction in Snail2 staining on the injected side, compared
to embryos injected with GFP, is shown for Snail2 ISHs. For c-Myc ISHs,
the percentage of embryos showing the phenotype is displayed.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1749-8104-5-1-
S6.JPEG]
Abbreviations
GFP: green fluorescent protein; ISH: in situ hybridization; PBS: phosphate-
buffered saline; phH3: phosphorylated histone H3; Ppa: Partner of paired;
RING: Really Interesting New Gene; SCF: Skp1-Cullin1-F-box; SEM: standard
error of the mean; TdT: Terminal Deoxynucleotidyl Transferase; TUNEL:
terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end
labeling.
Acknowledgements
The authors gratefully acknowledge Dr Axel Behrens (CRUK) for supplying
the anti-Cdc4 antibodies, and Therese Mitchell, Alison Jones and Dr Ian
Horan for technical assistance. HMW was funded by a Wellcome Trust
studentship. ADA was funded by a Fundacao Ciencia e Tecnologia
studentship and CJH by a CRUK studentship. Work in AP’s lab is funded by
MRC Research Grants G0500101 and G0700758. Work in RSH’s lab is funded
by a grant from the National Cancer Institute-National Institutes of Health
(R01CA095898).
Author details
1Department of Oncology, University of Cambridge, Hutchison-MRC
Research Centre, Addenbrookes Hospital, Hills Road, Cambridge, CB2 0XZ,
UK.
2Current address: Division of Virology, Department of Pathology,
University of Cambridge, Tennis Court Road, CB2 1QP, UK.
3Program in
Molecular Biology and Biotechnology, University of North Carolina at Chapel
Hill, Chapel Hill, NC 27599, USA.
4Department of Cell Biology and Physiology,
and Cancer Center, University of New Mexico Health Sciences Center,
Albuquerque, NM 87131, USA.
Authors’ contributions
ADA and HMW are joint first co-authors.
AP conceived the study, participated in its experimental design and
coordination, and helped draft and refine the manuscript. HMW participated
in study design, designed and undertook experiments and produced the
first draft of the manuscript. HMW, MKS and RSH contributed to generation
of new reagents and coordinated the collaboration. ADA designed and
undertook the experiments during the revision of the manuscript. AP, HMW,
ADA, CJH, MKS and RSH helped refine the manuscript. HMW was the sole
contributor to Figures 5, 6, 7, and 12 and Additional files 2, 3, 4, 5 and 6,
and the primary contributor to Figure 8. ADA was the primary contributor to
Figures 2, 3, 4, 9, 10 and 11. HMW and ADA contributed to Figure 1. MKS
was the primary contributor of Additional file 1. ADA and CJH contributed
to Figure 8. HMW, ADA, CJH, RSH and AP analyzed and interpreted the data.
All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 27 January 2009
Accepted: 4 January 2010 Published: 4 January 2010
References
1. Semple CA: The comparative proteomics of ubiquitination in mouse.
Genome Res 2003, 13:1389-1394.
2. Zheng N, Schulman BA, Song L, Miller JJ, Jeffrey PD, Wang P, Chu C,
Koepp DM, Elledge SJ, Pagano M, et al: Structure of the Cul1-Rbx1-Skp1-F
boxSkp2 SCF ubiquitin ligase complex. Nature 2002, 416:703-709.
3. Skowyra D, Craig KL, Tyers M, Elledge SJ, Harper JW: F-box proteins are
receptors that recruit phosphorylated substrates to the SCF ubiquitin-
ligase complex. Cell 1997, 91:209-219.
4. Bai C, Sen P, Hofmann K, Ma L, Goebl M, Harper JW, Elledge SJ: SKP1
connects cell cycle regulators to the ubiquitin proteolysis machinery
through a novel motif, the F-box. Cell 1996, 86:263-274.
5. Hartwell LH, Mortimer RK, Culotti J, Culotti M: Genetic Control of the Cell
Division Cycle in Yeast: V. Genetic Analysis of cdc Mutants. Genetics 1973,
74:267-286.
6. Verma R, Feldman RM, Deshaies RJ: SIC1 is ubiquitinated in vitro by a
pathway that requires CDC4, CDC34, and cyclin/CDK activities. Mol Biol
Cell 1997, 8:1427-1437.
7. Verma R, Annan RS, Huddleston MJ, Carr SA, Reynard G, Deshaies RJ:
Phosphorylation of Sic1p by G1 Cdk required for its degradation and
entry into S phase. Science 1997, 278:455-460.
8. Feldman RM, Correll CC, Kaplan KB, Deshaies RJ: A complex of Cdc4p,
Skp1p, and Cdc53p/cullin catalyzes ubiquitination of the phosphorylated
CDK inhibitor Sic1p. Cell 1997, 91:221-230.
9. Strohmaier H, Spruck CH, Kaiser P, Won KA, Sangfelt O, Reed SI: Human F-
box protein hCdc4 targets cyclin E for proteolysis and is mutated in a
breast cancer cell line. Nature 2001, 413:316-322.
10. Welcker M, Clurman BE: FBW7 ubiquitin ligase: a tumour suppressor at
the crossroads of cell division, growth and differentiation. Nat Rev Cancer
2008, 8:83-93.
11. Yada M, Hatakeyama S, Kamura T, Nishiyama M, Tsunematsu R, Imaki H,
Ishida N, Okumura F, Nakayama K, Nakayama KI: Phosphorylation-
Almeida et al. Neural Development 2010, 5:1
http://www.neuraldevelopment.com/content/5/1/1
Page 18 of 20dependent degradation of c-Myc is mediated by the F-box protein
Fbw7. Embo J 2004, 23:2116-2125.
12. Nateri AS, Riera-Sans L, Da Costa C, Behrens A: The ubiquitin ligase
SCFFbw7 antagonizes apoptotic JNK signaling. Science 2004, 303:1374-
1378.
13. Moberg KH, Bell DW, Wahrer DC, Haber DA, Hariharan IK: Archipelago
regulates Cyclin E levels in Drosophila and is mutated in human cancer
cell lines. Nature 2001, 413:311-316.
14. Oberg C, Li J, Pauley A, Wolf E, Gurney M, Lendahl U: The Notch
intracellular domain is ubiquitinated and negatively regulated by the
mammalian Sel-10 homolog. J Biol Chem 2001, 276:35847-35853.
15. Kitagawa K, Hiramatsu Y, Uchida C, Isobe T, Hattori T, Oda T, Shibata K,
Nakamura S, Kikuchi A, Kitagawa M: Fbw7 promotes ubiquitin-dependent
degradation of c-Myb: involvement of GSK3-mediated phosphorylation
of Thr-572 in mouse c-Myb. Oncogene 2009, 28:2393-2405.
16. Mao JH, Perez-Losada J, Wu D, Delrosario R, Tsunematsu R, Nakayama KI,
Brown K, Bryson S, Balmain A: Fbxw7/Cdc4 is a p53-dependent,
haploinsufficient tumour suppressor gene. Nature 2004, 432:775-779.
17. Tsunematsu R, Nakayama K, Oike Y, Nishiyama M, Ishida N, Hatakeyama S,
Bessho Y, Kageyama R, Suda T, Nakayama KI: Mouse Fbw7/Sel-10/Cdc4 is
required for notch degradation during vascular development. J Biol
Chem 2004, 279:9417-9423.
18. Cornell RA, Eisen JS: Notch in the pathway: the roles of Notch signaling
in neural crest development. Semin Cell Dev Biol 2005, 16:663-672.
19. Bellmeyer A, Krase J, Lindgren J, LaBonne C: The protooncogene c-myc is
an essential regulator of neural crest formation in xenopus. Dev Cell
2003, 4:827-839.
20. Meulemans D, Bronner-Fraser M: Gene-regulatory interactions in neural
crest evolution and development. Dev Cell 2004, 7:291-299.
21. Steventon B, Carmona-Fontaine C, Mayor R: Genetic network during
neural crest induction: from cell specification to cell survival. Semin Cell
Dev Biol 2005, 16:647-654.
22. Le Douarin NM, Creuzet S, Couly G, Dupin E: Neural crest cell plasticity
and its limits. Development 2004, 131:4637-4650.
23. Huang X, Saint-Jeannet JP: Induction of the neural crest and the
opportunities of life on the edge. Dev Biol 2004, 275:1-11.
24. Aybar MJ, Nieto MA, Mayor R: Snail precedes slug in the genetic cascade
required for the specification and migration of the Xenopus neural
crest. Development 2003, 130:483-494.
25. Mayor R, Morgan R, Sargent MG: Induction of the prospective neural crest
of Xenopus. Development 1995, 121:767-777.
26. Vernon AE, LaBonne C: Slug stability is dynamically regulated during
neural crest development by the F-box protein Ppa. Development 2006,
133:3359-3370.
27. Spevak W, Keiper BD, Stratowa C, Castanon MJ: Saccharomyces cerevisiae
cdc15 mutants arrested at a late stage in anaphase are rescued by
Xenopus cDNAs encoding N-ras or a protein with beta-transducin
repeats. Mol Cell Biol 1993, 13:4953-4966.
28. Lin HR, Chuang LC, Boix-Perales H, Philpott A, Yew PR: Ubiquitination of
cyclin-dependent kinase inhibitor, Xic1, is mediated by the Xenopus F-
box protein xSkp2. Cell Cycle 2006, 5:304-314.
29. Welcker M, Orian A, Jin J, Grim JE, Harper JW, Eisenman RN, Clurman BE:
The Fbw7 tumor suppressor regulates glycogen synthase kinase 3
phosphorylation-dependent c-Myc protein degradation. Proc Natl Acad
Sci USA 2004, 101:9085-9090.
30. Hong CS, Saint-Jeannet JP: The activity of Pax3 and Zic1 regulates three
distinct cell fates at the neural plate border. Mol Biol Cell 2007, 18:2192-
2202.
31. Aoki Y, Saint-Germain N, Gyda M, Magner-Fink E, Lee YH, Credidio C, Saint-
Jeannet JP: Sox10 regulates the development of neural crest-derived
melanocytes in Xenopus. Dev Biol 2003, 259:19-33.
32. Nakata K, Nagai T, Aruga J, Mikoshiba K: Xenopus Zic family and its role in
neural and neural crest development. Mech Dev 1998, 75:43-51.
33. Schlosser G, Ahrens K: Molecular anatomy of placode development in
Xenopus laevis. Dev Biol 2004, 271:439-466.
34. Pandur PD, Moody SA: Xenopus Six1 gene is expressed in neurogenic
cranial placodes and maintained in the differentiating lateral lines. Mech
Dev 2000, 96:253-257.
35. Koepp DM, Schaefer LK, Ye X, Keyomarsi K, Chu C, Harper JW, Elledge SJ:
Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw7
ubiquitin ligase. Science 2001, 294:173-177.
36. Welcker M, Singer J, Loeb KR, Grim J, Bloecher A, Gurien-West M,
Clurman BE, Roberts JM: Multisite phosphorylation by Cdk2 and GSK3
controls cyclin E degradation. Mol Cell 2003, 12:381-392.
37. Ye X, Nalepa G, Welcker M, Kessler BM, Spooner E, Qin J, Elledge SJ,
Clurman BE, Harper JW: Recognition of phosphodegron motifs in human
cyclin E by the SCF(Fbw7) ubiquitin ligase. J Biol Chem 2004, 279:50110-
50119.
38. Hao B, Oehlmann S, Sowa ME, Harper JW, Pavletich NP: Structure of a
Fbw7-Skp1-cyclin E complex: multisite-phosphorylated substrate
recognition by SCF ubiquitin ligases. Mol Cell 2007, 26:131-143.
39. Boix-Perales H, Horan I, Wise H, Lin HR, Chuang LC, Yew PR, Philpott A: The
E3 ubiquitin ligase Skp2 regulates neural differentiation independent
from the cell cycle. Neural Develop 2007, 2:27.
40. Richard-Parpaillon L, Cosgrove RA, Devine C, Vernon AE, Philpott A: G1/S
phase cyclin-dependent kinase overexpression perturbs early
development and delays tissue-specific differentiation in Xenopus.
Development 2004, 131:2577-2586.
41. Rempel RE, Sleight SB, Maller JL: Maternal Xenopus Cdk2-cyclin E
complexes function during meiotic and early embryonic cell cycles that
lack a G1 phase. J Biol Chem 1995, 270:6843-6855.
42. Sangfelt O, Cepeda D, Malyukova A, van Drogen F, Reed SI: Both SCF
(Cdc4alpha) and SCF(Cdc4gamma) are required for cyclin E turnover in
cell lines that do not overexpress cyclin E. Cell Cycle 2008, 7:1075-1082.
43. Vernon AE, Philpott A: The developmental expression of cell cycle
regulators in Xenopus laevis. Gene Expr Patterns 2003, 3:179-192.
44. Saka Y, Smith JC: Spatial and temporal patterns of cell division during
early Xenopus embryogenesis. Dev Biol 2001, 229:307-318.
45. Harris WA, Hartenstein V: Neuronal determination without cell division in
Xenopus embryos. Neuron 1991, 6:499-515.
46. Anderson JA, Lewellyn AL, Maller JL: Ionizing radiation induces apoptosis
and elevates cyclin A1-Cdk2 activity before but not after the midblastula
transition in Xenopus. Mol Biol Cell 1997, 8:1195-1206.
47. Hensey C, Gautier J: A developmental timer that regulates apoptosis at
the onset of gastrulation. Mech Dev 1997, 69:183-195.
48. Stack JH, Newport JW: Developmentally regulated activation of apoptosis
early in Xenopus gastrulation results in cyclin A degradation during
interphase of the cell cycle. Development 1997, 124:3185-3195.
49. Hensey C, Gautier J: Programmed cell death during Xenopus
development: a spatio-temporal analysis. Dev Biol 1998, 203:36-48.
50. Honore SM, Aybar MJ, Mayor R: Sox10 is required for the early
development of the prospective neural crest in Xenopus embryos. Dev
Biol 2003, 260:79-96.
51. Kee Y, Bronner-Fraser M: To proliferate or to die: role of Id3 in cell cycle
progression and survival of neural crest progenitors. Genes Dev 2005,
19:744-755.
52. Yeo W, Gautier J: A role for programmed cell death during early
neurogenesis in xenopus. Dev Biol 2003, 260:31-45.
53. Tribulo C, Aybar MJ, Sanchez SS, Mayor R: A balance between the anti-
apoptotic activity of Slug and the apoptotic activity of msx1 is required
for the proper development of the neural crest. Dev Biol 2004, 275:325-
342.
54. Vega S, Morales AV, Ocana OH, Valdes F, Fabregat I, Nieto MA: Snail blocks
the cell cycle and confers resistance to cell death. Genes Dev 2004,
18:1131-1143.
55. Voigt J, Papalopulu N: A dominant-negative form of the E3 ubiquitin
ligase Cullin-1 disrupts the correct allocation of cell fate in the neural
crest lineage. Development 2006, 133:559-568.
56. Yook JI, Li XY, Ota I, Fearon ER, Weiss SJ: Wnt-dependent regulation of the
E-cadherin repressor snail. J Biol Chem 2005, 280:11740-11748.
57. Barembaum M, Bronner-Fraser M: Early steps in neural crest specification.
Semin Cell Dev Biol 2005, 16:642-646.
58. Knochel S, Schuler-Metz A, Knochel W: c-Jun (AP-1) activates BMP-4
transcription in Xenopus embryos. Mech Dev 2000, 98:29-36.
59. Peng Y, Xu RH, Mei JM, Li XP, Yan D, Kung HF, Phang JM: Neural inhibition
by c-Jun as a synergizing factor in bone morphogenetic protein 4
signaling. Neuroscience 2002, 109:657-664.
60. Wei W, Jin J, Schlisio S, Harper JW, Kaelin WG Jr: The v-Jun point mutation
allows c-Jun to escape GSK3-dependent recognition and destruction by
the Fbw7 ubiquitin ligase. Cancer Cell 2005, 8:25-33.
61. Nieuwkoop PD, Faber J: Normal table of Xenopus laevis. New York: Garland
Publishing 1994.
Almeida et al. Neural Development 2010, 5:1
http://www.neuraldevelopment.com/content/5/1/1
Page 19 of 2062. Sive HL, Grainger RL, Harland RM: Early Development of Xenopus laevis. A
Laboratory Manual Cold Spring Harbour Laboratory Press 2000.
63. Butler K, Zorn AM, Gurdon JB: Nonradioactive in situ hybridization to
xenopus tissue sections. Methods 2001, 23:303-312.
64. Zhang W, Koepp DM: Fbw7 isoform interaction contributes to cyclin E
proteolysis. Mol Cancer Res 2006, 4:935-943.
65. Welcker M, Clurman BE: Fbw7/hCDC4 dimerization regulates its substrate
interactions. Cell Div 2007, 2:7.
66. Tang X, Orlicky S, Lin Z, Willems A, Neculai D, Ceccarelli D, Mercurio F,
Shilton BH, Sicheri F, Tyers M: Suprafacial orientation of the SCFCdc4
dimer accommodates multiple geometries for substrate ubiquitination.
Cell 2007, 129:1165-1176.
doi:10.1186/1749-8104-5-1
Cite this article as: Almeida et al.: The F-box protein Cdc4/Fbxw7 is a
novel regulator of neural crest development in Xenopus laevis. Neural
Development 2010 5:1.
Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Almeida et al. Neural Development 2010, 5:1
http://www.neuraldevelopment.com/content/5/1/1
Page 20 of 20